RAMP Trademark

Trademark Overview

On Thursday, October 25, 2018, a trademark application was filed for RAMP with the United States Patent and Trademark Office. The USPTO has given the RAMP trademark a serial number of 88169723. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by Inhibikase Therapeutics, Inc.. The RAMP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug research and design services which allow for technological design and development of small-molecule pharmaceuticals with pre-determined pharmacology
ramp

General Information

Serial Number88169723
Word MarkRAMP
Filing DateThursday, October 25, 2018
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6411753
Registration DateTuesday, July 6, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Goods and ServicesPharmaceutical drug research and design services which allow for technological design and development of small-molecule pharmaceuticals with pre-determined pharmacology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 8, 2018
Primary Code042
First Use Anywhere DateTuesday, June 30, 2020
First Use In Commerce DateTuesday, June 30, 2020

Trademark Owner History

Party NameABLI THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressATLANTA, GA 30339
Party NameInhibikase Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameInhibikase Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameInhibikase Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Friday, February 1, 2019ASSIGNED TO EXAMINER
Monday, October 29, 2018NEW APPLICATION ENTERED
Thursday, November 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 8, 2019PRIORITY ACTION WRITTEN
Friday, February 8, 2019PRIORITY ACTION E-MAILED
Friday, February 8, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, February 11, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, February 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 11, 2019EXAMINERS AMENDMENT E-MAILED
Monday, February 11, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 11, 2019EXAMINER'S AMENDMENT ENTERED
Monday, February 25, 2019ASSIGNED TO LIE
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 22, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 18, 2020SOU EXTENSION 2 FILED
Friday, November 22, 2019SOU EXTENSION 1 FILED
Friday, November 22, 2019SOU EXTENSION 1 GRANTED
Tuesday, November 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 18, 2020SOU TEAS EXTENSION RECEIVED
Monday, May 18, 2020SOU EXTENSION 2 GRANTED
Wednesday, May 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2020SOU TEAS EXTENSION RECEIVED
Monday, November 30, 2020SOU EXTENSION 3 FILED
Monday, November 30, 2020SOU EXTENSION 3 GRANTED
Wednesday, December 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 2, 2021TEAS STATEMENT OF USE RECEIVED
Sunday, May 2, 2021USE AMENDMENT FILED
Tuesday, June 1, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 13, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 2, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, June 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 4, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

ramp design molecule small pharmaceuticals development determined pharmacology allow research drug